GRAIL-Galleri: why the special treatment?

Turnbull, Clare; Wald, Nicholas; Sullivan, Richard; Pharoah, Paul; Houlston, Richard S; Aggarwal, Ajay; Hogarth, Stuart; McCartney, Margaret

Turnbull, Clare; Wald, Nicholas; Sullivan, Richard; Pharoah, Paul; Houlston, Richard S; Aggarwal, Ajay; Hogarth, Stuart; McCartney, Margaret.

Afiliação

Turnbull C; Division of Genetics and Epidemiology, Institute of Cancer Research, Royal Marsden NHS Trust, London SW3 6JJ, UK. Electronic address: clare.turnbull@icr.ac.uk.
Wald N; Institute of Health Informatics, University College London, London, UK.
Sullivan R; Institute of Cancer Policy (Global Oncology Group), King's College London, London, UK.
Pharoah P; Department of Computational Biomedicine, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Houlston RS; Division of Genetics and Epidemiology, Institute of Cancer Research, Royal Marsden NHS Trust, London SW3 6JJ, UK.
Aggarwal A; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, Guy's and St Thomas' NHS Trust, London, UK.
Hogarth S; Department of Sociology, University of Cambridge, Cambridge, UK.
McCartney M; Population and Behavioural Science Division, School of Medicine, University of St Andrews, St Andrews, UK; Fulton Street Medical Centre Glasgow, Glasgow, UK.

Lancet ; 403(10425): 431-432, 2024 Feb 03.

Article em En | MEDLINE | ID: mdl-38253053

Assuntos

Linfócitos T CD4-Positivos; Ubiquitina-Proteína Ligases; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Ubiquitina-Proteína Ligases Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google